Peripheral Arterial Disease: A Significant Opportunity for Interventional Therapies
Analyzes the peripheral interventional market in the aortoiliac, femoropopliteal and tibial vessels. Provides in-depth discussion of surgical bypass and grafts, angioplasty, stents, stent-grafts and other FDA-approved endovascular therapies. These include atherectomy, PolarCath cryoplasty, the CLiRpath excimer laser, the SilverHawk System, the cutting balloon and new devices to cross total occlusions.
Estimates current market potential for bypass surgery and endovascular therapies by disease severity and projects growth through 2020. Provides information and financial data for over 30 company participants.
Other users found this report page using the following search terms: PAD peripheral arterial disease bypass grafts angioplasty stents peripheral disease arterial prevalence market pad artery vascular bypass treatments
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.